Please provide your email address to receive an email when new articles are posted on . The addition of famitinib to first-line camrelizumab and nab-paclitaxel appeared active among patients with ...
“In 2015, when I started in this field…. people considered breast cancer a cold tumor,” Marleen Kok told the audience at the European Society of Medical Oncology’s 2022 Targeted Anticancer Therapy ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Given the dismal ...
‘Je eigen immuunsysteem helpen tumoren te herkennen en uitschakelen: dat is in feite wat immuuntherapie doet. Het werkt langdurig tegen kanker, doordat je immuunsysteem de kanker leert herkennen en ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback